Earnings summary: AbbVie reports mixed Q2 results; raises FY24 EPS outlook Posted on July 25, 2024 by wpadmin More on AbbVie: AbbVie Non-GAAP EPS of $2.65 misses by $0.01, revenue of $14.46B beats by $430M AbbVie: Why I Sold My Shares At $175 Cerevel Therapeutics gains as investors appear more confident on FTC approval for AbbVie
